$GRDN

Guardian Pharmacy Services reported their Q4 2025 earnings, indicating a steady growth in revenue driven by efficient delivery systems and enhanced customer satisfaction metrics. The company showed a 10% increase in year-over-year earnings, exceeding market expectations. However, challenges with supply chain disruptions and increasing operational costs were highlighted. The management aims to implement cost-reduction strategies and invest in technology to mitigate these issues. Overall, the outlook remains positive as they continue to expand their services.